Krystal Biotech Inc (KRYS)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 1.33 | — | — | — | — | |
| DSO | days | 275.17 | — | — | — | — |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 1.33
= 275.17
Based on the data provided, Krystal Biotech Inc's days of sales outstanding (DSO) as of December 31, 2023, stood at 275.17 days. DSO represents the average number of days it takes a company to collect revenue after a sale is made. A higher DSO indicates that the company is taking a longer time to collect its accounts receivable, which could potentially signal inefficiencies in the company's accounts receivable management or difficulties in collecting payments from customers. In the absence of DSO data for the prior years, it is challenging to assess the trend and how the current DSO compares to historical performance. Additional information and trend analysis would be necessary to gain deeper insights into Krystal Biotech Inc's accounts receivable management efficiency.
Peer comparison
Dec 31, 2023